Knight Therapeutics Completes the Tender Offer for Grupo Biotoscana And Achieves Over 95% Ownership
MONTREAL, Aug. 14, 2020 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading pan-American (ex-US) specialty pharmaceutical company, today announced the results of the tender offer process (“Tender Offer”) for the …